Loading clinical trials...

TERMINATEDPhase 2NCT02080962

Hypofractionated Radiotherapy for Nonmelanoma Skin Cancer

Radiotherapy is a treatment considered standard for non melanoma skin cancer. This institution uses schemes of 4 to 6 weeks of treatment. The objective of the study is to perform radiation therapy in ...

Lead sponsor: Barretos Cancer Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1/2

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

NCT07410676 · Cancer, Sarcoma, and more

RECRUITINGPhase 2

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

NCT04844528 · Chronic Lymphocytic Leukemia, Non-melanoma Skin Cancer (NMSC)

RECRUITINGNA

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

NCT03906253 · Actinic Keratoses, Aging, and more

RECRUITINGPhase 3

Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial

NCT05955924 · Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, and more

RECRUITINGNA

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

NCT06428721 · Actinic Keratoses, Aging, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 7, 2014Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment10

Start dateJan 2011

Last updatedMar 7, 2014

Condition

Non-melanoma Skin Cancer

Locations shown

Barretos Cancer Hospital - Fundacao Pio XII

Barretos, São Paulo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 7, 2014Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions